BTN3A2 is expressed in triple-negative breast cancer, pancreatic ductal carcinoma, and epithelial ovarian cancer, and is associated with a good prognosis (Le Page et al., 2012; Cai et al., 2020). The gene discussed is BTN3A2; the disease is ovarian carcinoma.